(Q40143602)

17 September 2017

title

GRADE EVIDENCE TO DECISION (EtD) FRAMEWORK FOR COVERAGE DECISIONS. (English)

1 reference

17 September 2017

Elena Parmelli

1

0 references

Pablo Alonso-Coello

4

object named as

Pablo Alonso-Coello

0 references

Andrew D. Oxman

3

object named as

Andrew D Oxman

1 reference

17 September 2017

10

Holger J Schünemann

1 reference

17 September 2017

Laura Amato

2

1 reference

17 September 2017

Pablo Alonso-Coello

4

1 reference

17 September 2017

Massimo Brunetti

5

1 reference

17 September 2017

Jenny Moberg

6

1 reference

17 September 2017

Francesco Nonino

7

1 reference

17 September 2017

Silvia Pregno

8

1 reference

17 September 2017

Carlo Saitto

9

1 reference

17 September 2017

Marina Davoli

11

1 reference

17 September 2017

GRADE Working Group

12

1 reference

17 September 2017

publication date

28 June 2017

1 reference

International Journal of Technology Assessment in Health Care

17 September 2017

published in

1 reference

17 September 2017

volume

33

1 reference

17 September 2017

issue

2

1 reference

17 September 2017

page(s)

176-182

1 reference

Creative Commons Attribution 4.0 International

17 September 2017

copyright license

start time

28 June 2017

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Men's preferences for prostate cancer screening: a discrete choice experiment.

1 reference

https://api.crossref.org/works/10.1017%2FS0266462317000447

Twenty years of using economic evaluations for drug reimbursement decisions: what has been achieved?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462317000447

Quality-of-life effects of prostate-specific antigen screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462317000447

Accountability for reasonableness

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462317000447

Challenges for Australia's Bio/Nanopharma Policies: trade deals, public goods and reference pricing in sustainable industrial renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462317000447

The role of value for money in public insurance coverage decisions for drugs in Australia: a retrospective analysis 1994-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462317000447

Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462317000447

Mapping of multiple criteria for priority setting of health interventions: an aid for decision makers

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462317000447

Using health technology assessment to support optimal use of technologies in current practice: the challenge of "disinvestment".

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462317000447

From efficacy to equity: Literature review of decision criteria for resource allocation and healthcare decisionmaking

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462317000447

A systematic review of coverage decision-making on health technologies-evidence from the real world

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462317000447

Coverage with evidence development: the Ontario experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462317000447

The role of economic evidence in Canadian oncology reimbursement decision-making: to lambda and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462317000447

GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462317000447

Developing and Evaluating Communication Strategies to Support Informed Decisions and Practice Based on Evidence (DECIDE): protocol and preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462317000447

Conceptual frameworks and key dimensions to support coverage decisions for vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462317000447

Performance-based risk-sharing arrangements-good practices for design, implementation, and evaluation: report of the ISPOR good practices for performance-based risk-sharing arrangements task force

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462317000447

GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462317000447

Quality of economic evaluations in health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462317000447

Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462317000447

Coverage with evidence development: an examination of conceptual and policy issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462317000447

7 January 2021

The GRADE evidence-to-decision framework: a report of its testing and application in 15 international guideline panels

1 reference

https://api.crossref.org/works/10.1017%2FS0266462317000447

7 January 2021

Making fair choices on the path to universal health coverage

1 reference

https://api.crossref.org/works/10.1017%2FS0266462317000447

7 January 2021

Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold

1 reference

https://api.crossref.org/works/10.1017%2FS0266462317000447

7 January 2021

10.1017/S0266462317000447

Identifiers

DOI

1 reference

17 September 2017

1 reference